TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Journal: Journal of Clinical Investigation

Published: 2021-04-15

DOI: 10.1172/jci139434

Affiliations: 7

Authors: 17

Go to article
Institutions Share
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.84
China Medical University (CMU), Taiwan 0.08
Purdue University, United States of America (USA) 0.03
Harbin Medical University (HMU), China 0.03
Asia University, Taiwan 0.02